221 related articles for article (PubMed ID: 36013253)
1. Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study.
Gallo S; Castelnuovo P; Spirito L; Feduzi M; Seccia V; Visca D; Spanevello A; Statuti E; Latorre M; Montuori C; Rizzi A; Boccabella C; Bonini M; De Corso E
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013253
[TBL] [Abstract][Full Text] [Related]
2. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.
Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G
Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399
[TBL] [Abstract][Full Text] [Related]
3. Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps.
Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; Carrillo-Díaz T; Del Rosario JJB
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831021
[TBL] [Abstract][Full Text] [Related]
4. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.
Can Bostan O; Duran E; Tuncay G; Cihanbeylerden M; Karadag O; Damadoglu E; Karakaya G; Kalyoncu AF
J Asthma; 2023 May; 60(5):931-937. PubMed ID: 35912568
[No Abstract] [Full Text] [Related]
6. Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care.
Galletti C; Ciodaro F; Barbieri MA; Gambino F; Ferrisi MG; Portelli D; Catalano N; Spina E; Freni F; Galletti B
Am J Otolaryngol; 2024; 45(4):104329. PubMed ID: 38696895
[TBL] [Abstract][Full Text] [Related]
7. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
8. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.
Desrosiers M; Diamant Z; Castelnuovo P; Hellings PW; Han JK; Peters AT; Silver J; Smith SG; Fuller A; Sousa AR; Chan RH; Gevaert P;
Int Forum Allergy Rhinol; 2024 Jan; 14(1):18-31. PubMed ID: 37345861
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye.
Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174
[No Abstract] [Full Text] [Related]
10. Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
Bachert C; Sousa AR; Han JK; Schlosser RJ; Sowerby LJ; Hopkins C; Maspero JF; Smith SG; Kante O; Karidi-Andrioti DE; Mayer B; Chan RH; Yancey SW; Chaker AM
J Allergy Clin Immunol; 2022 May; 149(5):1711-1721.e6. PubMed ID: 35007624
[TBL] [Abstract][Full Text] [Related]
11. Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients.
Bandi F; Gallo S; Preti A; Mozzanica F; Visca D; Marelli M; Maddalone E; Gambarini C; Vaghi A; Spanevello A; Castelnuovo P
Acta Otorhinolaryngol Ital; 2020 Dec; 40(6):435-443. PubMed ID: 33558772
[TBL] [Abstract][Full Text] [Related]
12. Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study.
Maza-Solano J; Calvo-Henríquez C; Alobid I; Álvarez-Cendrero M; Palomares Ó; Moreno-Luna R; Santos-Perez J; González-García J; Sánchez-Gómez S
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498632
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma.
Paçacı Çetin G; Arslan B; Yılmaz İ
J Asthma; 2024 Jan; 61(1):20-26. PubMed ID: 37437223
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study.
Cakmak ME; Öztop N; Yeğit OO; Özdedeoğlu Ö
Int Arch Allergy Immunol; 2023; 184(8):736-743. PubMed ID: 36996772
[TBL] [Abstract][Full Text] [Related]
15. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.
Detoraki A; Tremante E; Poto R; Morelli E; Quaremba G; Granata F; Romano A; Mormile I; Rossi FW; de Paulis A; Spadaro G
Respir Res; 2021 Jun; 22(1):185. PubMed ID: 34162391
[TBL] [Abstract][Full Text] [Related]
16. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
Tversky J; Lane AP; Azar A
Clin Exp Allergy; 2021 Jun; 51(6):836-844. PubMed ID: 33595845
[TBL] [Abstract][Full Text] [Related]
17. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
[TBL] [Abstract][Full Text] [Related]
18. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
Crimi C; Campisi R; Cacopardo G; Intravaia R; Nolasco S; Porto M; Pelaia C; Crimi N
World Allergy Organ J; 2020 Sep; 13(9):100462. PubMed ID: 32994855
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps.
Xu Z; Luo X; Xu L; Deng J; Gao W; Jiang L; Huang Z; Shi J; Lai Y
World Allergy Organ J; 2020 Jun; 13(6):100131. PubMed ID: 32566071
[TBL] [Abstract][Full Text] [Related]
20. Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
Özdel Öztürk B; Yavuz Z; Eraslan D; Mungan D; Demirel YS; Aydın Ö; Sin BA; Bavbek S
Int Arch Allergy Immunol; 2022; 183(5):526-538. PubMed ID: 34915496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
